Afya Limited (AFYA)
AFYANASDAQ-GSOther Consumer Services
$10.30
0.0000 (0.00%) today
At the close, Nov 17, 4:00 PM ET. Pre-market $10.44 +1.36%
- Market cap
- $978.47m
- P/E
- 5.8
- EPS, last 4 quarters
- $1.78
- Dividend yield
- 6.37%
- Day range
- –
- 52-week range
- $9.66 to $16.16
- Average volume
- –
- Previous close
- $10.30
Analysts
5 coveringHold4 buy, 1 hold, 0 sell
Targets a year out average $14.78, +43.5% from here
Earnings
next estimate $0.3300Next report
Dec 2025
+10.8%
Mar 2026
+1.9%
Jun 2026
-2.2%
Sep 2026
+8.3%
estimate reported, and the surprise
Financials
No quarterly figures from the source.
News
8 latest- Afya: 3 Key Takeaways for Long-Term InvestorsThe Motley Fool · 5 days ago
- Afya (AFYA) Q3 2026 Earnings Call TranscriptThe Motley Fool · 5 days ago
- What Afya (AFYA) Said on Its Q3 Earnings CallMarketBeat · 5 days ago
- Afya (AFYA) Q3 Earnings Lag EstimatesZacks · 6 days ago
- Afya (AFYA) Earnings Expected to Grow: Should You Buy?Zacks · Nov 4, 2026
- Afya Enters Oversold TerritoryBNK Invest · Oct 26, 2026
- Monday Sector Laggards: Water Utilities, Education & Training Services BNK Invest · Oct 26, 2026
- Afya Maps Yduqs Merger, BRL 2.2B Synergies and Digital Health Growth at Investor DayMarketBeat · Oct 23, 2026
The company
Afya is a leading medical education group in Brazil, based on the number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students and physicians to transform their ambitions into rewarding lifelong experiences from the moment they join us as medical students through their medical residency preparation, graduation program, continuing medical education activities and offering medical practice solutions to help doctors enhance their healthcare services through their whole career.
- Sector
- Real Estate
- Industry
- Other Consumer Services
- Exchange
- NASDAQ-GS
- Region
- South America
- Website
- afya.com.br
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.